Sign in
4

Changes in Ownership

Replimune Group, Inc. Filed Acc 0001104659-25-123286

Chief Medical Officer acquired 60,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Xynos Konstantinos Chief Medical Officer 2025-12-19 Grant or award +60,000 199,685 D
Loading xslF345X05/tm2533977-4_4seq1.xml…